PHRM 231 Lecture Notes - Lecture 9: Glycated Hemoglobin, Economic Evaluation, Calendar
Document Summary
Recognize the fact that health care resources are limited, and debate the impact of such resource scarcity on clinical care. Critically appraise a cost-effectiveness analysis report (e. g. a publication) Methods for measuring utility: standard gamble, time tradeoff (methodology for eliciting qualities in an individual, questionnaire-based methods (more practical) Model-based using external evidence (e. g. published literature) Data-driven using a single data source (often a pragmatic rct) To extrapolate cost and effectiveness beyond the data observed in a trial. A tree-like graph or model of decisions and possible consequences. Modeling the progression of individuals over time cycles across clinical stages of the disease. Definition : viewpoint from which the intervention"s costs and consequences are evaluated. Applies mostly to costs (sometimes also to effectiveness) Definition : period of time over which costs and consequences are evaluated. Should be long enough to capture all relevant outcomes. Often times, the evidence comes from longitudinal studies (e. g. rcts or cohorts)
